4b-Phorbol 12-Myristate 13-Acetate

Myristic Acid 9-ester with (+)-1,1aα,1bβ,4,4a,7aα,7b,8,9,9a-Decahydro-4aβ,7bα,9β,9aα-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8α-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one 9a-Acetate; [1aR-(1aα,1bβ,4aβ,7aα,7bα,8α,9β,9aα)]-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl Ester Tetradecanoic Acid; 1H-Cyclopropa[3,4]benz[1,2-e]azulene Tetradecanoic Acid Deriv. 12-O-Tetradecanoylphorbol 13-Acetate; 12-Tetradecanoylphorbol 13-Acetate; 12-Tetradecanoylphorbol 13-Monoacetate; 13-O-Acetylphorbol 12-Myristate; 4β-Phorbol 12-myristate 13-Acetate; Factor A1; Factor A1 (croton oil) NSC 262244; PMA; PMA (tumor promoter); Phorbol 12-myristate 13-Acetate; Phorbol 12-tetradecanoate 13-Acetate

InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30?,32-,34-,35-,36?/m1/s1